Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft Model
Induction of oxidative stress is a key component of cancer therapy. Pro-oxidant drugs have been demonstrated to enhance the efficacy of radiotherapy and chemotherapy. An emerging concept is that therapeutic outcomes are dictated by the differential redox buffering reserve in subpopulations of malign...
Main Authors: | Terry H. Landowski, Gerald P. Guntle, Dezheng Zhao, Bhumasamudram Jagadish, Eugene A. Mash, Robert T. Dorr, Natarajan Raghunand |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331630016X |
Similar Items
-
Early Response of Prostate Carcinoma Xenografts to Docetaxel Chemotherapy Monitored With Diffusion MRI
by: Dominique Jennings, et al.
Published: (2002-01-01) -
Applications of Magnetic Resonance in Model Systems: Cancer Therapeutics
by: Jeffrey L. Evelhoch, et al.
Published: (2000-01-01) -
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
by: Varduhi Petrosyan, et al.
Published: (2023-01-01) -
Tracking Tumor Cells in Lymphatics in a Mice Xenograft Model by Magnetic Resonance Imaging
by: Ting Liu, et al.
Published: (2012-11-01) -
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water
by: Jeffrey R. Brender, et al.
Published: (2023-09-01)